A recent study reveals that following updated guidelines to introduce peanut products to infants has led to a significant decrease in peanut allergies among young children. The study, conducted by Dr. David Hill at Children’s Hospital of Philadelphia, analyzed health records from various pediatric practices before and after the implementation of these guidelines.
The findings show that peanut allergies in children aged zero to three decreased by over 27% following the initial guidance in 2015 and by more than 40% after the recommendations were expanded in 2017. Despite this positive impact, the overall prevalence of food allergies in the U.S. has continued to rise, affecting approximately 8% of children, with over 2% having a peanut allergy.
The groundbreaking 2015 Learning Early About Peanut Allergy (LEAP) trial, led by Gideon Lack at King’s College London, demonstrated that introducing peanut products in infancy could reduce the risk of developing food allergies by more than 80%. Subsequent guidelines have emphasized the early introduction of allergenic foods, including peanuts, to babies between four and six months of age.
While the adoption of these guidelines has been slow in some areas, the study authors are encouraged by the positive impact observed. Dr. Derek Chu, a professor of medicine at McMaster University, notes the importance of consistent and early introduction of allergens to infants, emphasizing the safety of this approach. He suggests gradually introducing allergenic foods like peanuts in a controlled manner to minimize any potential risks.
Advocates for those with food allergies view these findings as a step in the right direction towards reducing the prevalence of peanut allergies nationwide. They emphasize the importance of clear guidance for parents on introducing allergenic foods to infants and the potential benefits of early allergen introduction in preventing allergies in children.